Imaging of Liposarcoma: Classification, Patterns of Tumor Recurrence, and Response to Treatment
Kevin N. O’Regan(Dana-Farber Cancer Institute), Nikhil H. Ramaiya(Brigham and Women's Hospital), Frederico Souza(Dana-Farber Cancer Institute), Katherine M. Krajewski(Brigham and Women's Hospital), Jyothi P. Jagannathan(Brigham and Women's Hospital), Katherine Zukotynski(Unknown), Andrew J. Wagner(Dana-Farber Cancer Institute)
Cited by 78
Related Papers
Imatinib for Melanomas Harboring Mutationally Activated or Amplified <i>KIT</i> Arising on Mucosal, Acral, and Chronically Sun-Damaged Skin
|Journal of Clinical Oncology|2013|594
Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial
|The Lancet|2019|472
Change in neutrophil-to-lymphocyte ratio (NLR) in response to immune checkpoint blockade for metastatic renal cell carcinoma
|Journal for ImmunoTherapy of Cancer|2018|267
Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network
|Annals of Oncology|2020|145
Pneumatosis Intestinalis and Bowel Perforation Associated With Molecular Targeted Therapy: An Emerging Problem and the Role of Radiologists in Its Management
|American Journal of Roentgenology|2012|109